Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Oct 2022 for Panbela Therapeutics, Inc.. Read the official filing
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Donald Robert Schemel: trading record in brief
Donald Robert Schemel is a declared insider of Panbela Therapeutics, Inc. (board member), with filings sourced from SEC (Form 4). The record holds 2 filings, for trades running from 25 May 2021 to 4 October 2022.
Every open-market trade on record is a purchase: 1 purchase, and no sale. The totals do not cover 1 filing with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant. 2022 to date brings 1 purchase and no sales.
The record was last updated on 6 October 2022 with an open-market purchase in Panbela Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Donald Robert Schemel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
200,000 sharesCommon StockSEC:0001437749-22-023773:0
Canonical exit: 2 Jan 2023 (T+90)
4,316 shares0Common StockSEC:0001437749-21-013594:0
2 of 2 declarations
